Update on medical management of inflammatory bowel disease: ulcerative colitis.

S. B. Hanauer*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


Significant advances have been made regarding our understanding of the etiopathogenesis of inflammatory bowel disease. This review focuses on the most recent applications of medical therapy for ulcerative colitis. Therapeutic approaches continue to evolve regarding inductive and maintenance strategies with oral and topical aminosalicylates, systemic and non-systemic corticosteroids, and cyclosporine and alternative immunomodulators. As further investigations continue to discern microbiological and immunoinflammatory targets, future therapies may include both probiotics and novel biological agents.

Original languageEnglish (US)
Pages (from-to)169-176
Number of pages8
JournalReviews in Gastroenterological Disorders
Issue number4
StatePublished - Jan 1 2001

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Update on medical management of inflammatory bowel disease: ulcerative colitis.'. Together they form a unique fingerprint.

Cite this